Literature DB >> 7041933

Measurement of the renal clearance of drugs.

G T Tucker.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7041933      PMCID: PMC1401922          DOI: 10.1111/j.1365-2125.1981.tb01304.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  45 in total

1.  Renal excretion by non-ionic diffusion: the nature of the disequilibrium.

Authors:  G H Mudge; P Silva; G R Stibitz
Journal:  Med Clin North Am       Date:  1975-05       Impact factor: 5.456

Review 2.  The binding of drugs to plasma proteins from patients with poor renal function.

Authors:  M M Reidenberg
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

3.  Time-dependent change in renal clearance of bethanidine in humans.

Authors:  A N Chremos; D Shen; M Gibaldi; J D Proctor; J H Newman
Journal:  J Pharm Sci       Date:  1976-01       Impact factor: 3.534

4.  Clinical pharmacokinetics in infants and children.

Authors:  A Rane; J T Wilson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 5.  Clincial pharmacokinetics in neonates.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Pharmacokinetics of bethanidine in hypertensive patients.

Authors:  D Shen; M Gibaldi; A Israili; G Bellward; R Cunningham; M Throne; P Dayton; J McNay
Journal:  Clin Pharmacol Ther       Date:  1975-03       Impact factor: 6.875

7.  Effect of experimental azotemia on renal clearance of furosemide in the dog.

Authors:  H J Rose; A W Pruitt; J L McNay
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

Review 8.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies.

Authors:  P H Hinderling; E R Garrett; R D Wester
Journal:  J Pharm Sci       Date:  1977-02       Impact factor: 3.534

10.  Depression of renal clearance of furosemide in man by azotemia.

Authors:  H J Rose; K O'Malley; A W Pruitt
Journal:  Clin Pharmacol Ther       Date:  1977-02       Impact factor: 6.875

View more
  28 in total

Review 1.  Measurement of renal function during drug development.

Authors:  D Craig Brater
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers.

Authors:  R Orlando; M Floreani; R Padrini; P Palatini
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 4.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

5.  Pharmacokinetics and milk secretion of gabapentin and meloxicam co-administered orally in Holstein-Friesian cows.

Authors:  P R Malreddy; J F Coetzee; B Kukanich; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2012-02-28       Impact factor: 1.786

6.  Metformin disposition-A 40-year-old mystery.

Authors:  Geoffrey T Tucker; Carl A Wesolowski
Journal:  Br J Clin Pharmacol       Date:  2020-05-11       Impact factor: 4.335

7.  Physiological modelling of renal drug clearance.

Authors:  I Janků
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Urinary tract infection.

Authors:  D Greenwood; R Slack
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

9.  Quantitative analysis of drug handling by the kidney using a physiological model of renal drug clearance.

Authors:  I Janků; K Zvára
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 10.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Aleksandra Galetin; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-08-09       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.